AP NEWS

Vyvanse API Insight Report 2018 - ResearchAndMarkets.com

December 19, 2018

DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Vyvanse - API Insight,2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Vyvanse - API Insight, 2018 report provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Vyvanse. The report also highlights the patent details of Vyvanse.

Key Topics Covered:

1. Vyvanse Overview

2. Vyvanse Global Sales Assessment

Vyvanse Historical Global Sales Vyvanse Forecasted Global Sales

3. Product Description

Mechanism of Action Pharmacodynamic Properties Pharmacokinetic Properties

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

Active Pharmaceutical Ingredient (API) Manufacturers by Country Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/lss6sr/vyvanse_api?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005738/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/19/2018 03:01 PM/DISC: 12/19/2018 03:01 PM

http://www.businesswire.com/news/home/20181219005738/en

AP RADIO
Update hourly